Intravenous injection of irradiated tumo
β
Aya Saito; Naoya Morishita; Chihomi Mitsuoka; Shunichi Kitajima; Katsuyuki Hamad
π
Article
π
2011
π
John Wiley and Sons
π
English
β 554 KB
## Abstract ## Background Although cancer therapy using replicationβselective oncolytic adenoviruses has been available for many years, its antiβtumor efficacy is suboptimal as a result of low and nonspecific infectivity that depends on coxsackie adenovirus receptor expression of the target cancer